Nasdaq
$23.64▼ 0.02%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $533.2MShares out 22.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 8.20Regular26.08.21 03:05144Ownership#●●●#●●●
TACTILE SYSTEMS TECHNOLOGY INC
William W. Burke, an insider at Tactile Systems Technology, filed an SEC Form 144 on August 20, 2026, to report a proposed sale of company shares. Investors should monitor this disclosure regarding the insider's planned divestment.…more
$23.64-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.12After-hours26.08.13 06:28SCHEDULE 13G/AOwnership
TACTILE SYSTEMS TECHNOLOGY INC
Morgan Stanley and its wholly-owned subsidiary, Morgan Stanley Capital Services LLC, filed a joint Schedule 13G on August 12, 2026, regarding their beneficial ownership of Tactile Systems Technology (TCMD). Morgan Stanley, as a parent holding company, maintains beneficial ownership of the shares held by its subsidiary.…more
$23.64-0.02%vs prev closeView filingShare - 8.12After-hours26.08.13 05:224Ownership
TACTILE SYSTEMS TECHNOLOGY INC
Insider Sheri Louise Dodd of Tactile Systems Technology executed a transaction involving company securities on August 10, 2026. This filing serves as a Form 4 report detailing the changes in the executive's beneficial ownership.…more
$23.64-0.02%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoAfter-hours26.10.20 05:05#●●●#●●●
Tactile Medical to Release Q3 2026 Financial Results on November 2
Tactile Medical announced that it will release its financial results for the third quarter of 2026 after the market closes on November 2. Management will host a conference call following the release to discuss the quarterly performance.…more
$23.64-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.10After-hours26.08.11 05:05
●●●●●●●● ●●●●● ●●●●●●
택타일 메디컬은 2분기 매출이 전년 동기 대비 9% 증가하며 견조한 성장세를 보였으나, 신제품 출시 관련 재고 조정 영향으로 연간 매출 가이던스를 소폭 하향 조정했습니다. 핵심 사업인 림프부종 부문의 성장이 지속되고 있으며, 수익성 개선과 함께 자사주 매입을 통한 주주 환원 정책을 병행하고 있습니다.…more
$23.64-0.02%vs prev close - 7.21After-hours26.07.22 05:05
●●●●●●●● ●●●●● ●●●●●●
택타일 메디컬은 2026년 8월 10일 장 마감 후 2분기 실적을 발표할 예정입니다. 경영진은 같은 날 컨퍼런스 콜을 통해 실적을 논의할 예정입니다.…more
$23.64-0.02%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report